Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
82.82 USD | +0.16% | -0.48% | +7.70% |
11:59am | Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target | MT |
May. 16 | Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.70% | 13.03B | |
+52.96% | 55.07B | |
-1.17% | 41.79B | |
+44.47% | 40.22B | |
-7.59% | 28.17B | |
+12.69% | 26.28B | |
-21.20% | 18.93B | |
+30.48% | 12.26B | |
+26.13% | 12.21B | |
-6.57% | 11.41B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation, Q3 2024 Earnings Call, May 01, 2024